Literature DB >> 27173948

Exome sequencing identified mutations in CASK and MYBPC3 as the cause of a complex dilated cardiomyopathy phenotype.

Eyal Reinstein1, Shay Tzur2, Concetta Bormans3, Doron M Behar3.   

Abstract

Whole-exome sequencing for clinical applications is now an integral part of medical genetics practice. Though most studies are performed in order to establish diagnoses in individuals with rare and clinically unrecognizable disorders, due to the constantly decreasing costs and commercial availability, whole-exome sequencing has gradually become the initial tool to study patients with clinically recognized disorders when more than one gene is responsible for the phenotype or in complex phenotypes, when variants in more than one gene can be the cause for the disease. Here we report a patient presenting with a complex phenotype consisting of severe, adult-onset, dilated cardiomyopathy, hearing loss and developmental delay, in which exome sequencing revealed two genetic variants that are inherited from a healthy mother: a novel missense variant in the CASK gene, mutations in which cause a spectrum of neurocognitive manifestations, and a second variant, in MYBPC3, that is associated with hereditary cardiomyopathy. We conclude that although the potential for co-occurrence of rare diseases is higher when analyzing undefined phenotypes in consanguineous families, it should also be given consideration in the genetic evaluation of complex phenotypes in non-consanguineous families.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27173948      PMCID: PMC6865166          DOI: 10.1017/S0016672316000045

Source DB:  PubMed          Journal:  Genet Res (Camb)        ISSN: 0016-6723            Impact factor:   1.588


  13 in total

1.  A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3.

Authors:  Pablo Cingolani; Adrian Platts; Le Lily Wang; Melissa Coon; Tung Nguyen; Luan Wang; Susan J Land; Xiangyi Lu; Douglas M Ruden
Journal:  Fly (Austin)       Date:  2012 Apr-Jun       Impact factor: 2.160

2.  Mutations in TAX1BP3 cause dilated cardiomyopathy with septo-optic dysplasia.

Authors:  Eyal Reinstein; Katia Orvin; Einav Tayeb-Fligelman; Hadas Stiebel-Kalish; Shay Tzur; Allen L Pimienta; Lily Bazak; Tuvia Bengal; Lior Cohen; Dan D Gaton; Concetta Bormans; Meytal Landau; Ran Kornowski; Mordechai Shohat; Doron M Behar
Journal:  Hum Mutat       Date:  2015-03-16       Impact factor: 4.878

Review 3.  Inherited cardiomyopathies.

Authors:  Jeffrey A Towbin
Journal:  Circ J       Date:  2014-09-02       Impact factor: 2.993

4.  CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes.

Authors:  Anna Hackett; Patrick S Tarpey; Andrea Licata; James Cox; Annabel Whibley; Jackie Boyle; Carolyn Rogers; John Grigg; Michael Partington; Roger E Stevenson; John Tolmie; John Rw Yates; Gillian Turner; Meredith Wilson; Andrew P Futreal; Mark Corbett; Marie Shaw; Jozef Gecz; F Lucy Raymond; Michael R Stratton; Charles E Schwartz; Fatima E Abidi
Journal:  Eur J Hum Genet       Date:  2009-12-23       Impact factor: 4.246

5.  Spectrum of pontocerebellar hypoplasia in 13 girls and boys with CASK mutations: confirmation of a recognizable phenotype and first description of a male mosaic patient.

Authors:  Lydie Burglen; Sandra Chantot-Bastaraud; Catherine Garel; Mathieu Milh; Renaud Touraine; Ginevra Zanni; Florence Petit; Alexandra Afenjar; Cyril Goizet; Sabina Barresi; Aurélie Coussement; Christine Ioos; Leila Lazaro; Sylvie Joriot; Isabelle Desguerre; Didier Lacombe; Vincent des Portes; Enrico Bertini; Jean-Pierre Siffroi; Thierry Billette de Villemeur; Diana Rodriguez
Journal:  Orphanet J Rare Dis       Date:  2012-03-27       Impact factor: 4.123

Review 6.  Mechanisms of disease: hypertrophic cardiomyopathy.

Authors:  Norbert Frey; Mark Luedde; Hugo A Katus
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

Review 7.  Genetic mutations and mechanisms in dilated cardiomyopathy.

Authors:  Elizabeth M McNally; Jessica R Golbus; Megan J Puckelwartz
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 8.  How do MYBPC3 mutations cause hypertrophic cardiomyopathy?

Authors:  Steven Marston; O'Neal Copeland; Katja Gehmlich; Saskia Schlossarek; Lucie Carrier; Lucie Carrrier
Journal:  J Muscle Res Cell Motil       Date:  2011-11-05       Impact factor: 2.698

9.  Phenotypic spectrum associated with CASK loss-of-function mutations.

Authors:  Ute Moog; Kerstin Kutsche; Fanny Kortüm; Bettina Chilian; Tatjana Bierhals; Neophytos Apeshiotis; Stefanie Balg; Nicolas Chassaing; Christine Coubes; Soma Das; Hartmut Engels; Hilde Van Esch; Ute Grasshoff; Marisol Heise; Bertrand Isidor; Joanna Jarvis; Udo Koehler; Thomas Martin; Barbara Oehl-Jaschkowitz; Els Ortibus; Daniela T Pilz; Prab Prabhakar; Gudrun Rappold; Isabella Rau; Günther Rettenberger; Gregor Schlüter; Richard H Scott; Moonef Shoukier; Eva Wohlleber; Birgit Zirn; William B Dobyns; Gökhan Uyanik
Journal:  J Med Genet       Date:  2011-09-27       Impact factor: 6.318

10.  Phenotypic and molecular insights into CASK-related disorders in males.

Authors:  Ute Moog; Tatjana Bierhals; Kristina Brand; Jan Bautsch; Saskia Biskup; Thomas Brune; Jonas Denecke; Christine E de Die-Smulders; Christina Evers; Maja Hempel; Marco Henneke; Helger Yntema; Björn Menten; Joachim Pietz; Rolph Pfundt; Jörg Schmidtke; Doris Steinemann; Constance T Stumpel; Lionel Van Maldergem; Kerstin Kutsche
Journal:  Orphanet J Rare Dis       Date:  2015-04-12       Impact factor: 4.123

View more
  2 in total

1.  Novel CASK mutations in cases with syndromic microcephaly.

Authors:  Francesca Cristofoli; Koen Devriendt; Erica E Davis; Hilde Van Esch; Joris R Vermeesch
Journal:  Hum Mutat       Date:  2018-05-11       Impact factor: 4.878

2.  Case Report: Identification of a novel CASK missense variant in a Chinese family with MICPCH.

Authors:  Runfeng Zhang; Peng Jia; Yanyi Yao; Feng Zhu
Journal:  Front Genet       Date:  2022-08-25       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.